[A monoclonal antibody directed against a protein (CD20) expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope I 131 with potential antineoplastic activity. Iodine 131 tositumomab delivers radiation selectively to neoplastic CD20-expressing B-lymphocytes cells, thereby decreasing the risk of systemic radiotoxicity. ( NCI )]
UMLS (NCI) C0768182I 131 Bexxar
I 131 Monoclonal Antibody Anti-B1
I 131 Tositumomab
I131-MOAB-B1
Iodine I 131 MOAB Anti-B1
Iodine I 131 Monoclonal Antibody Anti-B1
Iodine I 131 Tositumomab
Iodine-131 Anti-B1 Antibody
Iodine-131 Anti-CD20 Monoclonal Antibody
Iodine-131 Tositumomab
TOSITUMOMAB IODINE-131
TOSITUMOMAB IODINE-131 PREPARATION
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor
Relation/PAR: anti-B1
Unclassified Ingredients
Relation/CHD: TOSITUMOMAB IODINE-131 0.61 MCI/ML
TOSITUMOMAB IODINE-131 VIAL 5.6MCI/ML